Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions
Fredrik Åberg, Martti Färkkilâ
Seminars in Liver Disease (2020) Vol. 40, Iss. 02, pp. 154-162
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Changing epidemiology, global trends and implications for outcomes of NAFLD
Vincent Wai‐Sun Wong, Mattias Ekstedt, Grace Lai‐Hung Wong, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 842-852
Open Access | Times Cited: 287
Mitochondrial alterations in fatty liver diseases
Bernard Fromenty, Michael Roden
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. 415-429
Open Access | Times Cited: 204
Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement
Hannes Hagström, Leon A. Adams, Alina M. Allen, et al.
Hepatology (2021) Vol. 74, Iss. 1, pp. 474-482
Open Access | Times Cited: 164
Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease
Fredrik Åberg, Christopher D. Byrne, Carlos J. Pirola, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 191-206
Open Access | Times Cited: 151
Lifestyle interventions in nonalcoholic fatty liver disease
Zobair M. Younossi, Shira Zelber‐Sagi, Linda Henry, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 11, pp. 708-722
Closed Access | Times Cited: 136
Metabolic dysfunction–associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease
Fasiha Kanwal, Brent A. Neuschwander‐Tetri, Rohit Loomba, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1212-1219
Open Access | Times Cited: 88
Supervised Machine Learning Models for Liver Disease Risk Prediction
Ηλίας Δρίτσας, Μαρία Τρίγκα
Computers (2023) Vol. 12, Iss. 1, pp. 19-19
Open Access | Times Cited: 64
Impact of MASLD and MetALD on clinical outcomes: A meta‐analysis of preliminary evidence
Stefano Ciardullo, Alessandro Mantovani, Mario Luca Morieri, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1762-1767
Closed Access | Times Cited: 16
Alcohol-associated liver disease—Global epidemiology
Fredrik Åberg, Z. Gordon Jiang, Helena Cortez‐Pinto, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1307-1322
Closed Access | Times Cited: 16
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, et al.
Clinical and Molecular Hepatology (2021) Vol. 28, Iss. 2, pp. 150-163
Open Access | Times Cited: 76
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group
Stuart McPherson, Matthew J. Armstrong, Jeremy Cobbold, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 8, pp. 755-769
Open Access | Times Cited: 52
Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score
Fredrik Åberg, Panu K. Luukkonen, Anna But, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 302-311
Open Access | Times Cited: 49
Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis
Helen Jarvis, Hannah O’Keefe, Dawn Craig, et al.
BMJ Open (2022) Vol. 12, Iss. 1, pp. e049767-e049767
Open Access | Times Cited: 43
Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis
Song Lu, Qiyang Xie, Maobin Kuang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 35
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions
Stefano Ciardullo, Emanuele Muraca, Michela Vergani, et al.
Gastroenterology report (2023) Vol. 12
Open Access | Times Cited: 33
MAFLD: an optimal framework for understanding liver cancer phenotypes
Harry Crane, Cameron Gofton, Ankur Sharma, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 10, pp. 947-964
Open Access | Times Cited: 27
Association of changes in waist circumference, waist-to-height ratio and weight-adjusted-waist index with multimorbidity among older Chinese adults: results from the Chinese longitudinal healthy longevity survey (CLHLS)
Zi-Ting Chen, Xiaomeng Wang, Yi-Shi Zhong, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
MetALD: Does it require a different therapeutic option?
George Marek, Harmeet Malhi
Hepatology (2024) Vol. 80, Iss. 6, pp. 1424-1440
Closed Access | Times Cited: 8
Diabetes and metabolic dysfunction-associated fatty liver disease
Timothy M. E. Davis
Metabolism (2021) Vol. 123, pp. 154868-154868
Closed Access | Times Cited: 47
Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease
Julie Massart, Karima Begriche, Anne Corlu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1062-1062
Open Access | Times Cited: 30
Meta‐analysis: The impact of light‐to‐moderate alcohol consumption on progressive non‐alcoholic fatty liver disease
Louise Magherman, Robbe Van Parys, N. Pauwels, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 8, pp. 820-836
Open Access | Times Cited: 17
Food inequity and insecurity and MASLD: burden, challenges, and interventions
Shira Zelber‐Sagi, Patrizia Carrieri, Juan M. Pericàs, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 10, pp. 668-686
Closed Access | Times Cited: 8
Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans
Tatsunori Miyata, Xiaoqin Wu, Xiude Fan, et al.
JCI Insight (2021) Vol. 6, Iss. 4
Open Access | Times Cited: 37
Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Luping Wang, Bowen Sang, Zuyan Zheng
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 20
Normative Modeling Reveals Age‐Atypical Cortical Thickness Differences Between Hepatic Steatosis and Fibrosis in Non‐Alcoholic Fatty Liver Disease
Minchul Kim, Inpyeong Hwang, Kyu Sung Choi, et al.
Brain and Behavior (2025) Vol. 15, Iss. 4
Open Access
Page 1 - Next Page

Scroll to top